
January 25, 2022
RegMed Investors’ (RMi) pre-open: wait, one dramatic and wild session with recovery does not make a sustainable sector
January 20, 2022
RegMed Investors’ (RMi) closing bell: finally, the oversold were appreciative until the lower reverse unfolded
January 13, 2022
RegMed Investors’ (RMi) closing bell: sector is still shackled by selling
January 12, 2022
RegMed Investors’ (RMi) closing bell: the cell and gene therapy sector went off the road and into a ditch, again
January 4, 2022
RegMed Investors’ (RMi) pre-open: first week’s a joy ride enhanced by a “January Effect”
December 17, 2021
RegMed Investors’ (RMi) closing bell: a cell and gene therapy sector rotation in a frenetic and churning ascension
December 16, 2021
RegMed Investors’ (RMi) closing bell: it’s better to leave early to avoid the sector’s decline
December 15, 2021
RegMed Investors’ (RMi) closing bell: back in the upside/positive zone
December 15, 2021
RegMed Investors’ (RMi) pre-open: a bounce after an upcoming Fed decision?
35 companies, 1 interpreter!
Insight, foresight and recommendation
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors